Federal Lobbying and the CIRM Mission
The California stem cell agency opened a huge door earlier this spring when it decided to back industry legislation in Washington to protect biotech therapy patents against development of generic equivalents.
Now marching across that portal is a bid to have the directors of the $3 billion state research institute engage in even broader lobbying efforts. …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.